Video
5m Watch
November 17, 2025
ANTIMICROBIAL STEWARDSHIP
prod:prod_dcx-login
The Need
- Surgical-site infections (SSIs) are a significant cause of morbidity and mortality1
- S. aureus is one of the most common pathogens responsible for SSIs2
- SSIs caused by MRSA lead to worse clinical outcomes vs less resistant pathogens2
- The use of inappropriate initial antibiotic treatment can be associated with adverse clinical outcomes and increased length of stay3
1 Mengistu DA, Alemu A, Abdukadir AA, Mohammed Husen A, Ahmed F, Mohammed B, Musa I. Global Incidence of Surgical Site Infection Among Patients: Systematic Review and Meta-Analysis. Inquiry. 2023 Jan-Dec;60:469580231162549. doi: 10.1177/00469580231162549. PMID: 36964747; PMCID: PMC10041599.
2 Seidelman JL, Mantyh CR, Anderson DJ. Surgical Site Infection Prevention: A Review. JAMA. 2023;329(3):244–252. doi:10.1001/jama.2022.24075
3 Nathwani D, et al. Early clinical assessment of response to treatment of skin and soft-tissue infections: how can it help clinicians? Perspectives from Europe. Int J Antimicrob Agents. 2016
2 Seidelman JL, Mantyh CR, Anderson DJ. Surgical Site Infection Prevention: A Review. JAMA. 2023;329(3):244–252. doi:10.1001/jama.2022.24075
3 Nathwani D, et al. Early clinical assessment of response to treatment of skin and soft-tissue infections: how can it help clinicians? Perspectives from Europe. Int J Antimicrob Agents. 2016
The Solution
The Xpert MRSA/SA SSTI test is a qualitative in vitro diagnostic test intended for the detection of Staphylococcus aureus (SA) and methicillin-resistant Staphylococcus aureus (MRSA) from skin and soft tissue infection swabs
- Laboratory efficiencies with on-demand workflows requiring minimal hands-on time
- Optimized therapy to support improved patient outcomes and reduced empirical prescribing
The Impact
- Rapid detection enables more targeted antibiotic selection4
- Patient management with informed treatment decisions
- Provides results in approximately 1 hour
4 May LS, et al. A Randomized Clinical Trial Comparing Use of Rapid Molecular Testing for Staphylococcus aureus for Patients With Cutaneous Abscesses in the Emergency Department With Standard of Care. Infect Control Hosp Epidemiol. 2015
